These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13458979)

  • 61. Management of carcinoma of the larynx and laryngo-pharynx; recent experiences.
    KORKIS FB
    Laryngoscope; 1959 Apr; 69(4):358-84. PubMed ID: 13655706
    [No Abstract]   [Full Text] [Related]  

  • 62. [Luminescent-cytologic method of diagnosis of cancer of the pharynx and larynx].
    GUTKINA AV
    Vestn Otorinolaringol; 1953; 15(6):58-63. PubMed ID: 13136777
    [No Abstract]   [Full Text] [Related]  

  • 63. [Value of angiography in the evaluation of pharyngolaryngeal tumors].
    Baron F; Legent F; Herzog B; Giudicelli G; Mitard D
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1972 Sep; 21(7):621-3. PubMed ID: 4263738
    [No Abstract]   [Full Text] [Related]  

  • 64. [Prolonged oral medication of Bayer E39 (cytostatic)].
    HESSE F; KAMPEN G
    Krebsarzt; 1957 Jun; 12(3):150-6. PubMed ID: 13450292
    [No Abstract]   [Full Text] [Related]  

  • 65. [The role of radiodiagnosis in the therapy of pharyngolaryngeal tumours].
    Magno L; Viviani G
    Arch Ital Otol Rinol Laringol; 1966; 77(4):475-98. PubMed ID: 4382927
    [No Abstract]   [Full Text] [Related]  

  • 66. [Effects of the cytotoxic drug Bayer E 39 in malignant tumors of the eyelids].
    PILLAT A
    Wien Klin Wochenschr; 1958 May; 70(21):383-6. PubMed ID: 13570068
    [No Abstract]   [Full Text] [Related]  

  • 67. [Local treatment of malignant eyelid tumors with Bayer E 39].
    PILLAT A
    Krebsarzt; 1958 Jan; 13(1):30-5. PubMed ID: 13526248
    [No Abstract]   [Full Text] [Related]  

  • 68. [Critical observations on therapy of malignancy with the cytostatic Bayer A 139 in otorhinolaryngological therapeutics].
    NIEMEYER W
    Dtsch Med J; 1958 Jul; 9(7):387-9. PubMed ID: 13561805
    [No Abstract]   [Full Text] [Related]  

  • 69. [Is the chemotherapy of malignant tumors justified today].
    MANSTEIN B
    Med Klin; 1957 Oct; 52(41):1796-9. PubMed ID: 13483016
    [No Abstract]   [Full Text] [Related]  

  • 70. [Proposed classification of malignant tumors of the larynx].
    DENOIX PF; BACLESSE F
    Ann Otolaryngol; 1957 Jun; 74(6):389-94. PubMed ID: 13444944
    [No Abstract]   [Full Text] [Related]  

  • 71. [Possibility of localizing isotope therapy in malignant mesopharyngeal tumors].
    SCHWAB W; SCHEER KE
    Arch Ohren Nasen Kehlkopfheilkd; 1960; 176():579-83. PubMed ID: 13749037
    [No Abstract]   [Full Text] [Related]  

  • 72. [Ambulant treatment of malignant diseases of the lymphatic system].
    BOHNEL J; STACHER A
    Medizinische; 1958 May; 3(21):871-4. PubMed ID: 13551732
    [No Abstract]   [Full Text] [Related]  

  • 73. [Peculiarities in the course of malignant diseases of the hemopoietic & lymphoreticular systems under cytostatic treatment].
    SIEGENTHALER W; KEISER G; ZOLLINGER HU
    Z Klin Med; 1959; 155(6):568-601. PubMed ID: 13648600
    [No Abstract]   [Full Text] [Related]  

  • 74. [Cytostatic treatment of malignant tumors with alcoxyethyleneimino-benzoquinone; Bayer E 39].
    SCHWERMER B; SCHREIBER HW
    Dtsch Med Wochenschr; 1958 Feb; 83(9):331-8. PubMed ID: 13512076
    [No Abstract]   [Full Text] [Related]  

  • 75. [Clinical observations on the therapeutic effects of a cyanogenetic glycuronoside in cases of human malignant neoplasms].
    TASCA M
    Gazz Med Ital; 1959 Apr; 118(4):153-9. PubMed ID: 13664049
    [No Abstract]   [Full Text] [Related]  

  • 76. [Pathological and anatomical findings on human tumors after chemotherapy (E 39)].
    BRAREN F
    Zentralbl Allg Pathol; 1957 Aug; 96(9-11):507-19. PubMed ID: 13497037
    [No Abstract]   [Full Text] [Related]  

  • 77. [Care of the mesopharyngeal defects after extirpation of malignant tumors in this area].
    DENECKE HJ
    Arch Ohren Nasen Kehlkopfheilkd; 1960; 176():645-9. PubMed ID: 13721837
    [No Abstract]   [Full Text] [Related]  

  • 78. [Results of treatment of carcinoma in women with the cytostic agents E 39 and A 139].
    KERN G
    Geburtshilfe Frauenheilkd; 1959 Mar; 19(3):226-9. PubMed ID: 13640214
    [No Abstract]   [Full Text] [Related]  

  • 79. Experiences with E-39 in the treatment of advanced malignant neoplasms.
    BRUNSCHWIG A
    Cancer; 1958; 11(4):765-8. PubMed ID: 13561244
    [No Abstract]   [Full Text] [Related]  

  • 80. [Chorion carcinoma].
    TEN BERGE B
    Ned Tijdschr Geneeskd; 1958 Apr; 102(17):801-2. PubMed ID: 13552848
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.